Oivin Guicherit in

Oivin Guicherit

Login to view DISC.
Director, Translational Biology at Broad Institute of MIT and Harvard
📍 Cambridge, Massachusetts, United States

A leader with over 25 years of experience in biotechnology and pharmaceuticals, specializing in drug discovery, translational biology, and stem cell therapeutics. He currently serves as the Director of Translational Biology at the Broad Institute, leveraging his Ph. D. from Baylor College of Medicine and postdoctoral work at Stanford University to advance novel therapies.

He shows a strong interest in supporting and connecting innovators, whether in data science or creative fields. His social media activity indicates he is a vocal supporter of Studio Guicherit, an architectural design firm, suggesting an appreciation for design and entrepreneurship.

He is an outspoken advocate for Phenotypic Screening as a powerful method for drug discovery.

Read the full overview →
Experience
27 Years
Current Role
Director, Translational Biology
Job Level
Mid-senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Oivin shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Oivin cares about

Translational Science
As Director of Translational Biology, his core mission is to bridge deep biological insights with the development of new therapeutics at the Broad Institute's CDoT.
Stem Cell Therapeutics
His background includes senior roles at SanBio and StemoniX, focusing on iPSC and MSC-based regenerative medicines for neurological disorders.
+5 more topics Login to view topics
Career

Work history

3-2022
Director, Translational Biology
Broad Institute of MIT and Harvard
1-2021 - 2-2022
Senior Director, Research
SanBio, Inc.
3-2017 - 12-2020
Sr. Director, Drug Discovery
StemoniX
8-2014 - 2-2017
Principal Scientist
Janssen, Pharmaceutical Companies of Johnson and Johnson
1-2013 - 7-2014
Associate Director
Regulus, Inc.
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1995 - 1998
Postdoctoral Fellow
Stanford University
1988 - 1994
Doctor of Philosophy (PhD)
Baylor College of Medicine
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Oivin. Free, 10 seconds.